Organigram Global (OGI) Cash from Investing Activities (2018 - 2026)
Organigram Global (OGI) posted quarterly Cash from Investing Activities of -$4.2 million for Q1 2026, up 41.53% year-over-year from -$3.0 million in Q1 2025, and down 34.72% quarter-over-quarter from -$3.1 million in Q4 2025.
Organigram Global (OGI) Cash from Investing Activities (2018 - 2026) Analysis & Trends
Organigram Global (OGI) has reported Cash from Investing Activities for 7 consecutive years, with -$4.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 41.53% year-over-year to -$4.2 million; the TTM figure through Mar 2026 stood at -$58.6 million (up 65.75% YoY), while the FY2025 annual figure was -$58.9 million, down 160.87% from the prior year.
- Cash from Investing Activities eased to -$4.2 million in Q1 2026 per OGI's latest filing, from -$3.1 million in the prior quarter.
- Across five years, Cash from Investing Activities topped out at -$3.1 million in Q4 2025 and bottomed at -$44.1 million in Q4 2024.
- Historically, Cash from Investing Activities has averaged -$14.6 million across 3 years, with a median of -$5.7 million in 2025.
- Annual changes were most pronounced in 2025 — Cash from Investing Activities jumped 92.93% — and 2026, when it jumped 41.53%.
- Organigram Global's Cash from Investing Activities stood at -$44.1 million in 2024, then surged by 92.93% to -$3.1 million in 2025, then slumped by 34.72% to -$4.2 million in 2026.
- Business Quant data shows OGI's Cash from Investing Activities at -$4.2 million in Q1 2026, -$3.1 million in Q4 2025, and -$7.2 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn | -491.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | -300.00 Mn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | -550.24 Mn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn | 87.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -51.60 Mn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn | -135.40 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn | -110.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Organigram Global | 151.93 Mn | 151.81 Mn | 28.97 Mn | -5.99 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.20 Mn |
| Mar 31, 2026 | -4.20 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Dec 31, 2025 | -3.12 Mn |
| Mar 31, 2025 | -7.18 Mn |
| Mar 31, 2025 | -7.18 Mn |
| Dec 31, 2024 | -44.06 Mn |
| Dec 31, 2024 | -44.06 Mn |
| May 31, 2021 | -153.91 Mn |
| May 31, 2021 | -153.91 Mn |
| Feb 28, 2021 | 34.18 Mn |
| Feb 28, 2021 | 34.18 Mn |
| Nov 30, 2020 | 15.81 Mn |
| Nov 30, 2020 | 15.81 Mn |
| Aug 31, 2020 | -177.81 Mn |
| Aug 31, 2020 | -177.81 Mn |
| May 31, 2020 | -23.37 Mn |
| May 31, 2020 | -23.37 Mn |
| Feb 29, 2020 | 68,052.00 |
| Feb 29, 2020 | 68,052.00 |